Skip to Content

93 7700 (Glimepiride and Rosiglitazone Maleate 2 mg / 8 mg)

Pill with imprint 93 7700 is Pink, Round and has been identified as Glimepiride and Rosiglitazone Maleate 2 mg / 8 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Glimepiride/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/rosiglitazone 2 mg / 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7700

Glimepiride and Rosiglitazone Maleate

Imprint
93 7700
Strength
2 mg / 8 mg
Color
Pink
Shape
Round
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7700

Get help with Imprint Code FAQs.

More about glimepiride / rosiglitazone

Consumer resources

Other brands
Avandaryl

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.